BARICITINIB

Clinical trials for BARICITINIB explained in plain language.

Never miss a new study

Get alerted when new BARICITINIB trials appear

Sign up with your email to follow new studies for BARICITINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Anti-Inflammatory drug could boost stroke recovery after clot removal

Disease control Not yet recruiting

This study tests whether adding the anti-inflammatory drug baricitinib to standard clot-removal treatment helps people recover better after a severe stroke caused by a blocked artery in the front of the brain. About 750 adults will receive either baricitinib or a placebo for five…

Matched conditions: BARICITINIB

Phase: PHASE2, PHASE3 • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control

Last updated Jun 27, 2026 09:10 UTC

BARICITINIB

Get alerted when new BARICITINIB trials appear

Anti-Inflammatory drug could boost stroke recovery after clot removal